Synthesis and Biological Evaluations of Betulinic Acid Derivatives With Inhibitory Activity on Hyaluronidase and Anti-Inflammatory Effects Against Hyaluronic Acid Fragment Induced Inflammation

Zhujun Luo, Hao He, Tiantian Tang, Jun Zhou, Huifang Li, Navindra P. Seeram, Dongli Li, Kun Zhang, Hang Ma, Panpan WuFrontiers in Chemistry 2022 · DOI

Introduction

Hyaluronic acid (HA) plays a dual role in physiological processes. High-molecular-weight HA serves as a lubricant and anti-inflammatory agent, whereas its degradation by the enzyme hyaluronidase (HAase) into low-molecular-weight fragments (LMWHAs) triggers pro-inflammatory signaling. Excessive HA degradation is a hallmark of various inflammatory diseases. While natural pentacyclic triterpenoids like betulinic acid (BA) possess some HAase inhibitory potential, their natural potency is insufficient for therapeutic applications. This study explores the synthesis of BA derivatives modified with an $\alpha,\beta$-unsaturated ketene moiety to enhance their anti-inflammatory and HAase-inhibitory properties.

Methodology

The researchers synthesized two series of BA derivatives using Claisen-Schmidt condensation to introduce an $\alpha,\beta$-unsaturated ketene moiety at the C-3 position.

  • Series 1: Retained the C-28 carboxylic acid group.
  • Series 2: Converted the C-28 group into a methyl ester.

Biological evaluation involved in vitro enzymatic assays against HAase and cell-based models using BV2 (murine microglia), RAW264.7 (murine macrophages), and THP-1 (human monocytes). Inflammation was induced using either Lipopolysaccharide (LPS) or specific HA fragments to assess the compounds' ability to reduce nitric oxide (NO) and pro-inflammatory cytokines like IL-6.

Results and Key Insights

The structural modifications significantly enhanced biological activity. Series 1 derivatives showed substantial HAase inhibition, ranging from 26.3% to 72.8%, compared to only 22.6% for the parent BA compound. In contrast, Series 2 (methyl esters) exhibited negligible activity, highlighting the critical role of the C-28 free carboxylic acid for enzyme binding.

Chemical structures, HAase inhibition curves, and molecular docking of BA derivatives.

Compound BA-06 was identified as the most potent inhibitor with an $IC_{50}$ of 18.3 μM. Beyond enzymatic inhibition, these derivatives demonstrated robust anti-inflammatory effects. In BV2 and RAW264.7 cells, they reduced LPS-induced nitrite production by up to 46.8% and 49.2%, respectively. Crucially, the compounds also suppressed inflammation specifically induced by HA fragments in human THP-1 cells, reducing IL-6 secretion and NO production.

Molecular Docking and Binding Mechanism

Computational modeling provided a structural basis for the observed potency. Docking studies of the most active derivatives revealed that the $\alpha,\beta$-unsaturated ketene moiety facilitates deeper penetration into the HAase hydrophilic pocket. The C-28 carboxylic acid acts as a molecular "anchor," forming essential hydrogen bonds with amino acid residues such as Arg196, Arg240, and Arg20. This multi-point interaction stabilizes the inhibitor-enzyme complex, explaining the superior performance of Series 1 over the parent compound and the inactive methyl esters.

Conclusion and Future Directions

This study successfully demonstrates that targeted modification of the betulinic acid skeleton can yield potent hyaluronidase inhibitors with significant anti-inflammatory potential. While these in vitro results are promising, further research is needed to evaluate these compounds in in vivo models to assess metabolic stability and bioavailability. Additionally, given the molecular weight of these triterpenoids, their ability to cross the blood-brain barrier remains a challenge for treating neuroinflammatory conditions, necessitating future investigations into specialized drug delivery systems.

Summary updated

Abstract

We previously reported that the structural modifications of pentacyclic triterpenoids including oleanolic acid resulted in enhanced hyaluronidase inhibitory activity but whether this applies to other pentacyclic triterpenoids such as betulinic acid (BA) is unknown. Herein, we synthesized BA derivatives with an α,β-unsaturated ketene moiety and evaluated for their: 1) hyaluronidase inhibitory activity and, 2) anti-inflammatory effects against lipopolysaccharides (LPS) induced inflammation. Compared to BA, the BA derivatives exerted improved anti-hyaluronidase activity (26.3%-72.8% vs. 22.6%) and anti-inflammatory effects by reducing nitrite production in BV2 cells (3.9%-46.8% vs. 3.4%) and RAW264.7 cells (22.7%-49.2% vs. 20.4%). BA derivatives inhibited LPS-induced production of pro-inflammatory cytokines in THP-1 cells (15.2%-22.4%). BA derivatives also exerted promising anti-inflammatory effects against hyaluronic acid fragment induced nitrite production (8.6%-35.6%) in THP-1 cells. BA derivatives showed augmented anti-hyaluronidase and anti-inflammatory effects but further biological evaluations using <i>in vivo</i> models are warranted to confirm their efficacy.
BibTeX
@inproceedings{luo2022synthesis,
  author = {Zhujun Luo and Hao He and Tiantian Tang and Jun Zhou and Huifang Li and Navindra P. Seeram and Dongli Li and Kun Zhang and Hang Ma and Panpan Wu},
  title = {{Synthesis and Biological Evaluations of Betulinic Acid Derivatives With Inhibitory Activity on Hyaluronidase and Anti-Inflammatory Effects Against Hyaluronic Acid Fragment Induced Inflammation}},
  booktitle = {Frontiers in Chemistry},
  year = {2022},
  doi = {10.3389/fchem.2022.892554},
}
Figure